Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Search

Page Path
HOME > Search
1 "Anastasia Mashukova"
Filter
Filter
Article category
Publication year
Original Article
Microbiota
Exploring the link between celiac disease and obesity: a potential role of gut microbiome
Sunaina Addanki, Anastasia Mashukova, Arkene Levy
Intest Res 2025;23(2):193-201.   Published online November 8, 2024
DOI: https://doi.org/10.5217/ir.2024.00049
AbstractAbstract PDFPubReaderePub
Background/Aims
In today’s age, celiac disease (CD) is no longer solely characterized by chronic diarrhea in a malnourished child. Obesity is gradually being acknowledged as part of CD’s clinical course. Both conditions have been linked to alterations of gut microbiome. Given the difficulty of strict gluten-free diet adherence, there is a need for less restrictive adjunctive therapies. We aimed to investigate the prevalence of obesity in patients diagnosed with CD with the goal of developing new therapeutic approaches.
Methods
Baseline data from the National Institute of Health’s All of Us Research Program, was used to evaluate the relationship between CD and obesity. A retrospective cohort study was conducted where groups of individuals with CD and without CD were matched by age range and health surveys. Statistical analysis with odds ratios (OR) with 95% confidence intervals (CI) were reported.
Results
The prevalence of obesity was 32.6% in the CD group compared to 18.4% in the control group (OR, 2.111; 95% CI, 1.914–2.328; P< 0.0001). Women accounted for a greater population of patients with CD and obesity. The largest percentage of patients with CD and obesity were older than 65 years. The highest percentage of individuals in both the experimental and control groups were white, followed by African Americans.
Conclusions
Our data shows a significant association between CD and increased prevalence of obesity. These results warrant further investigation into microbial changes and dietary exposures that affect the pathogenesis of both diseases.

Citations

Citations to this article as recorded by  
  • The epidemiology of inflammatory bowel disease: exploring the impacts of environmental factors
    Jihye Park, Jae Hee Cheon
    The Korean Journal of Internal Medicine.2026; 41(2): 186.     CrossRef
  • Prevalence and factors associated with obesity in patients with inflammatory bowel disease (IBD) treated with infliximab and vedolizumab across the UK
    Christopher Roberts, Phoebe Hodges, Fakhirah Badrulhisham, Rebecca Smith, Jennie Clough, Claire Bewshea, Vida Cairnes, Richard Pollok, Nick Powell, Nicholas A Kennedy, Anthi Thangarajah, Tariq Ahmad, James Goodhand
    Frontline Gastroenterology.2026; : flgastro-2026-103688.     CrossRef
  • Celiac Disease and Metabolic Diseases: A Review of Emerging Connections
    Deirdre Reidy, Christopher Cao, Alexandra Rosenstock, Melissa Stoffels, Sonal Kumar, Haley M. Zylberberg
    Current Treatment Options in Gastroenterology.2025;[Epub]     CrossRef
  • 6,862 View
  • 175 Download
  • 2 Web of Science
  • 3 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP